Risk factor
Very vulnerable to price shocks
Profitability factor
Undervalued vs peers
About
Aspen Pharmacare Holdings Limited, together with its subsidiaries, manufactures and supplies specialty and branded pharmaceutical products worldwide. It operates in Commercial Pharmaceuticals and Manufacturing segments. The company provides general anesthetics, muscle relaxants, and topical agents under the Anaesthetics brand; and a range of injectable anticoagulants with a focus on low molecular weight heparins, Xa inhibitors,...
Company Valuation
Based on key historical and expected multiples, the stock is undervalued relative to its peers. In particular, the stock is underpriced on P/E, of fair value on EV/EBITDA
Target Price
The average target price of APN.JO is 12567 and suggests 34% upside potential. Usually, this means a BUY recommendation among investment firms, or a recommendation to inc
Buy
Sell